四重暴露/难治性多发性骨髓瘤:既往接受过抗 CD38、IMiDs、蛋白酶体抑制剂与 BCMA 靶向治疗的患者 Quad-Exposed/Refractory Multiple Myeloma: Patients Previously Treated With Anti-CD38, IMiDs, Proteasome Inhibitors, and BCMA-Targeted Therapies. PubMed 2026/05/06 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 靶点:CD38靶点:BCMA多发性骨髓瘤淋巴瘤白血病地区:欧洲
免疫治疗在成人急性白血病治疗中处于何种地位? Where do immunotherapies stand in management of acute leukemia in adults? PubMed 2025/12/05 发表Hematology Am Soc Hematol Educ ProgramQ1 · IF 3.7(JCR 2025) 人群:成人靶点:CD19靶点:CD38靶点:CD7技术:CAR-T急性淋巴细胞白血病急性髓系白血病
儿童急性淋巴细胞白血病的新型治疗方法 Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia. PubMed 2025/11/24 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 人群:儿童靶点:CD19靶点:CD22靶点:CD38技术:CAR-T技术:双特异性抗体
SOHO 最新进展与后续问题 | 骨髓瘤早期复发的治疗:非 CAR-T 细胞 SOHO State of the Art Updates and Next Questions | Treatment of Myeloma Early Relapse: Non-CAR T Cell. PubMed 2025/10/04 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 靶点:CD38靶点:BCMA靶点:GPRC5D技术:CAR-T技术:双特异性抗体多发性骨髓瘤淋巴瘤白血病
复发/难治性儿童 T 细胞急性淋巴细胞白血病治疗的基础生物学、挑战与新概念 Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia. PubMed 2025/08/14 发表LeukemiaQ1 · IF 8.8(JCR 2025) 人群:儿童靶点:CD38靶点:CD7技术:CAR-T急性淋巴细胞白血病地区:欧洲
CAR-T 细胞治疗急性髓系白血病:目前所处的位置 CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now? PubMed 2025/05/30 发表Curr OncolQ2 · IF 3.6(JCR 2025) 靶点:CD19靶点:CD38靶点:CD123技术:CAR-T急性髓系白血病慢性淋巴细胞白血病
BNT162b2 mRNA 疫苗接种影响滤泡性淋巴瘤和慢性淋巴细胞白血病患者的肠道微生物组组成 BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia. PubMed 2025/02/10 发表Biomark ResQ1 · IF 14.6(JCR 2025) 靶点:CD20靶点:CD38技术:NK 细胞技术:mRNA慢性淋巴细胞白血病滤泡性淋巴瘤淋巴瘤
CD38 作为肿瘤学中的诊疗靶点 CD38 as theranostic target in oncology. PubMed 2024/11/05 发表J Transl MedQ1 · IF 9.7(JCR 2025) 靶点:CD38多发性骨髓瘤实体瘤白血病地区:欧洲
OMIP-106:用于分析急性髓系白血病患者骨髓中检查点抑制网络的 30 色方案 OMIP-106: A 30-color panel for analysis of check-point inhibitory networks in the bone marrow of acute myeloid leukemia patients. PubMed 2024/08/27 发表Cytometry AQ2 · IF 2.9(JCR 2025) 人群:成人靶点:CD38技术:CAR-T技术:NK 细胞技术:双特异性抗体急性髓系白血病
通过适配体 CAR-T 细胞 (AdCAR-T) 的合理组合靶向预防急性髓系白血病中的抗原逃逸 Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia. PubMed 2024/08/03 发表LeukemiaQ1 · IF 8.8(JCR 2025) 人群:儿童靶点:CD38靶点:CD123技术:CAR-T急性髓系白血病地区:欧洲